AVITA Medical (RCEL) EBITDA (2019 - 2026)
AVITA Medical (RCEL) EBITDA from Sep 30, 2019 to Mar 31, 2026. The TTM AVITA Medical (RCEL) EBITDA is -$37M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
AVITA Medical (RCEL) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -25.55% |
| 3 Years TTM | +10.60% |
| 5 Years TTM | +52.73% |
| All Time TTM | +12.97% |
Annual EBITDA change of AVITA Medical (RCEL)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$8.18M | -79.65% |
| 2025 | -$40M | -27.55% |
| 2024 | -$55M | +32.01% |
| 2023 | -$42M | +55.98% |
| 2022 | -$27M | +4.34% |
| 2021 | -$26M | +358.61% |
| 2020 | -$5.63M | -46.33% |
| 2019 | -$10M | +67.57% |
| 2018 | -$6.26M | -44.89% |
| 2017 | -$11M | N/A |
Comparison AVITA Medical (RCEL) five years EBITDA CAGR with competitors
AVITA Medical (RCEL) five years EBITDA CAGR is 21.56%.